Vancouver, BC – November 5, 2019 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to… Read More
Vancouver, BC – November 4, 2019 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing technology for the production of pharmaceutical-grade… Read More
Vancouver BC – November 5th, 2019 – Innovative Targeting Solutions (ITS) today announced that, A2 Biotherapeutics, Inc., co-founded in 2018 with Alexander Kamb, former SVP of Research at Amgen Inc., has… Read More
SAN DIEGO, Nov. 5, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new cancer therapies, today announced it will host… Read More
October, 31, 2019, Vancouver, B.C., – AbCellera, a leader in therapeutic antibody discovery from natural immune systems, has appointed Dr. Michael Hayden to its Board of Directors. Dr. Hayden replaces former… Read More
